Crispr gene editing concept

CRISPR-Cas9 is a revolutionary gene-editing tool that allows precise DNA modification, opening possibilities for curing genetic diseases and advancing agriculture.

About this subject

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a bacterial defense system discovered in 1987, but its application as a gene-editing tool was demonstrated in 2012 by Jennifer Doudna and Emmanuelle Charpentier. The system uses a Cas9 enzyme associated with a guide RNA that recognizes a specific DNA target sequence, making a double-strand break. This mechanism allows precise insertion, deletion, or substitution of genes.

Editing occurs when the cell repairs the cut through natural pathways: non-homologous end joining (NHEJ) or homology-directed repair (HDR). NHEJ often introduces small insertions or deletions that can inactivate a gene, while HDR allows insertion of a custom sequence. Due to its simplicity and cost-effectiveness, CRISPR has eclipsed earlier techniques like ZFNs and TALENs.

In medicine, CRISPR is being tested in clinical trials for diseases such as sickle cell disease, beta-thalassemia, and certain cancers. In 2023, the UK approved the first CRISPR-based treatment for sickle cell disease and beta-thalassemia, called Casgevy. In agriculture, non-browning mushrooms and tomatoes with higher lycopene are examples of edited crops. However, editing germline cells and human embryos raises ethical debates about unintended consequences and eugenics.

Frequently Asked Questions

What is CRISPR-Cas9 and how does it work?

CRISPR-Cas9 is a gene-editing tool derived from a bacterial immune system. It uses a Cas9 protein and a guide RNA to cut DNA at a specific site, allowing genes to be inserted, deleted, or modified.

What are the main medical applications of CRISPR?

CRISPR is used in research to develop treatments for genetic diseases like sickle cell anemia, muscular dystrophy, and cystic fibrosis. It is also explored in cancer therapies and rapid diagnosis of viral infections.

What are the ethical risks of using CRISPR in humans?

Key risks include off-target edits that can cause unintended mutations, and germline editing that is heritable and could affect future generations, raising eugenics and safety concerns.